Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BriaCell Therapeutics Corp


Ticker Change

Company Profile for BriaCell Therapeutics Corp (ACP)

BriaCell Therapeutics Corp. operates as a breast cancer immunotherapy biotech research and developer. The Company developed a patented whole-cell vaccine, cancer immunotherapy technology called the "BriaVax" vaccine. BriaCell has offices in North America.

Contact Information

BriaCell Therapeutics Corp

Bellevue Center 235
15th Street
Vancouver, BC V7T 2X1
Phone: 1-604-921-1810
Fax: 1-604-921-1898

Key Executives for BriaCell Therapeutics Corp (ACP)

Charles L WisemanChairman/CEORahoul SharanChief Financial Officer
Senthamil SelvanPrincipal ScientistSteven J O'DayPrincipal Investigator

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil